Development of pharmacophore models for predicting HIV-1 reverse transcriptase inhibitory activity of pyridinone derivatives

Author： Rani P.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.45, Iss.1, 2011-04, pp. : 36-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors

By Andreola Marie-Line   Nguyen Chi Hung   Ventura Michel   Tarrago-Litvak Laura   Legraverend Michel  

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 225-238

Informa Healthcare

Access to resources Recommend Favorite

QSAR Study on Pyridinone Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor: A Mixed Approach

By  

Medicinal Chemistry, Vol. 3, Iss. 3, 2007-05 ,pp. : 227-232

Bentham Science Publishers

Access to resources Recommend Favorite

Topochemical Models for Prediction of Anti-HIV Activity of 4-Benzyl Pyridinone Derivatives

By Bajaj Sanjay   Sambi S.   Madan A. K.  

Drug Development and Industrial Pharmacy, Vol. 31, Iss. 10, 2005-12 ,pp. : 1041-1051

Informa Healthcare

Access to resources Recommend Favorite

Novel C-organosilicon derivatives as leads for reverse-transcriptase-mediated anti-HIV-1 activity

By Delord B.   Guillorit M.   Lafay J.   Andreola M.   Tharaud D.   Tarrago-Litvak L.   Fleury H.   Deleris G.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 2, 1996-01 ,pp. : 111-122

Elsevier

Access to resources Recommend Favorite

TSAO Derivatives, Inhibitors of HIV-1 Reverse Transcriptase Dimerization: Recent Progress

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1895-1907

Bentham Science Publishers

Access to resources Recommend Favorite